Ubrelvy (ubrogepant) and Nurtec ODT (rimegepant) are brand-name oral tablets. They’re both prescribed for treating migraine in adults. This article explains the main similarities and differences ...

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 45 th Annual Health Care Conference on March 4, ...

The Department of Justice (DoJ) claims that Biohaven – before being acquired by Pfizer – paid "improper remuneration" to some Nurtec ODT (rimegepant) prescribers in the form of speaker fees ...

The table below provides a general comparison between Ubrelvy and Nurtec: Nurtec Orally Disintegrating Tablet (ODT) is a prescription medication taken to treat and prevent migraines in adults.

Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 15 development-stage product candidates. The information set forth herein does not purport to be complete or to contain all of the information you may ...

This was primarily driven by legacy Seagen, Vyndaqel family, Eliquis, Nurtec ODT/Vydura, and Xtandi, partially offset by lower revenues for Abrysvo, Xeljanz and Oncology biosimilars. Read Next ...

The Super Bowl logo has become more of a talking point among NFL fans over the last few seasons. Part of the reason for that is a conspiracy theory that the colors of the Super Bowl logo determine ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

Nurtec ODT/Vydura globally, up 39% operationally, driven primarily by strong demand in the U.S. and, to a much lesser extent, recent launches in international markets, partially offset by lower ...

On Monday, three logos were revealed to the public, one for each potential nickname, but NHL fans weren't particularly impressed by the latest round of options. Much of the criticism was focused ...

Pharma giant Pfizer has agreed to pay $59 million to settle a federal lawsuit accusing a local biopharmaceutical company of paying “kickbacks” to healthcare providers to induce them to prescribe its ...